Moderate Ulcerative colitis Completed Phase 1 Trials for Izencitinib (DB16660)

Also known as: Ulcerative Colitis, Active Moderate / Moderate, active Ulcerative colitis

IndicationStatusPhase
DBCOND0020388 (Moderate Ulcerative colitis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02818686TD-1473 for Active Ulcerative Colitis (UC)Treatment